Trimethylamine-N-oxide acutely increases cardiac muscle contractility

Cardiovascular disease is a major cause of morbidity and mortality among patients with chronic kidney disease (CKD). Trimethylamine-N-oxide (TMAO), a uremic metabolite that is elevated in the setting of CKD, has been implicated as a nontraditional risk factor for cardiovascular disease. While associ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Physiol Heart Circ Physiol
Auteurs principaux: Oakley, Carlee I., Vallejo, Julian A., Wang, Derek, Gray, Mark A., Tiede-Lewis, LeAnn M., Shawgo, Tilitha, Daon, Emmanuel, Zorn, George, Stubbs, Jason R., Wacker, Michael J.
Format: Artigo
Langue:Inglês
Publié: American Physiological Society 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346532/
https://ncbi.nlm.nih.gov/pubmed/32243768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00507.2019
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires